Business

Akoustis to Attend the 14th Annual Craig-Hallum Alpha Select Conference on November 16, 2023

Charlotte, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer

articleAktis Oncology, Inc.November 14, 20235/company/aktis-oncology-inc-common-stock/news/akoustis-to-attend-the-14th-annual-craig-hallum-alpha-select-conference-on-november
Akoustis to Attend the 14th Annual Craig-Hallum Alpha Select Conference on November 16, 2023

About this update from Aktis Oncology, Inc.

[{"type":"text","content":"Charlotte, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that founder and CEO Jeff Shealy will attend the 14th Annual Craig-Hallum Alpha Select Conference being held at the Sheraton New York Times Square Hotel on November 16, 2023. Investors that would like to schedule a meeting with Akoustis management should contact their Craig-Hallum representative or Akoustis’ investor relations at [email protected]. Akoustis maintains its momentum with robust demand and an expanding sales pipeline for its XBAW® filter products, in addition to its new XBAW®/SAW resonator and oscillator products, and semiconductor back-end services. The Company continues to secure new Wi-Fi design wins in its target markets including Wi-Fi, 5G Infrastructure, and Automotive, many of which are slated to ramp into production in the coming months. About Akoustis Technologies, Inc. Akoustis® (http://www.akoustis.com/) is a high-tech BAW RF filter solutions company that is pioneering next-generation materials science and MEMS wafer manufacturing to address the market requirements for improved RF filters — targeting higher bandwidth, higher operating frequencies and higher output power compared to legacy polycrystalline BAW technology. The Company utilizes its proprietary and patented XBAW® manufacturing process to produce bulk acoustic wave RF filters for mobile and other wireless markets, which facilitate signal acquisition and accelerate band performance between the antenna and digital back end. Superior performance is driven by the significant advances of poly-crystal, single-crystal, and other high purity piezoelectric materials and the resonator-filter process technology which enables optimal trade-offs between critical power, frequency and bandwidth performance specifications. Akoustis plans to service the fast growing multi-billion-dollar RF filter market using its integrated device manufacturer (IDM) business model. The Company owns and operates a 125,000 sq. ft. ISO-9001:2015 registered commercial wafer-manufacturing facility located in Canandaigua, NY, which includes a class 100 / class 1000 cleanroom facility — tooled for 150-mm diam...

More updates from Aktis Oncology, Inc.